Definitive Healthcare (NASDAQ:DH) Updates Q2 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its second quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.08-$0.09 for the period, compared to the consensus EPS estimate of $0.09. The company issued revenue guidance of $62.0-$63.5 million, compared to the consensus revenue estimate of $65.19 million. Definitive Healthcare also updated its FY24 guidance to $0.36-$0.38 EPS.

Analysts Set New Price Targets

DH has been the topic of a number of recent research reports. Morgan Stanley cut shares of Definitive Healthcare from an overweight rating to an equal weight rating and reduced their price target for the company from $11.50 to $9.00 in a research report on Wednesday. Needham & Company LLC restated a hold rating on shares of Definitive Healthcare in a report on Wednesday. Barclays increased their price target on Definitive Healthcare from $10.00 to $11.00 and gave the company an equal weight rating in a report on Friday, March 1st. Stifel Nicolaus reduced their price objective on Definitive Healthcare from $11.00 to $9.50 and set a buy rating on the stock in a research note on Wednesday. Finally, Canaccord Genuity Group lowered their target price on Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a research note on Wednesday. Eight analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of Hold and an average target price of $10.81.

Definitive Healthcare Stock Performance

NASDAQ:DH traded down $1.90 during trading hours on Wednesday, reaching $5.35. 5,266,918 shares of the stock were exchanged, compared to its average volume of 613,781. The stock has a market capitalization of $630.18 million, a P/E ratio of -3.01, a P/E/G ratio of 6.12 and a beta of 1.41. The firm has a 50 day simple moving average of $7.70 and a 200-day simple moving average of $8.29. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20. Definitive Healthcare has a 52 week low of $4.38 and a 52 week high of $12.45.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The business had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. As a group, sell-side analysts forecast that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.